JESSE BALLS: Open Payments
NPI 1487026191 · JEROME, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$149 in 8 payments from 5 companies in 2025. Trend: 2023 $149 · 2024 $111 · 2025 $149
Food & beverage: $149
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Exact Sciences Corporation | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: Ozempic, FARXIGA, Cologuard Collection Kit, CAPLYTA, AIRSUPRA, TREMFYA.
Industry payments across ID — which companies pay providers there.
